Compare Pfizer Inc (PFE) vs Exxon Mobil Corporation (XOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Exxon Mobil Corporation — how do they compare? Pfizer Inc trades at $24.91 (market cap $142.14B), while Exxon Mobil Corporation trades at $155.4 (market cap $628.83B). The key difference: Exxon Mobil Corporation is far larger — about 4.4× Pfizer Inc's market cap, and Pfizer Inc pays the higher dividend (6.9%). Which is the better fit depends on your goals.
| PFE | XOM | |
|---|---|---|
Market Cap | $142.14B | $628.83B |
Volume | 29,869,932 | — |
Sector | Health | Energy |
52-Week High | $28.56 | $171.52 |
52-Week Low | $23.29 | $105.83 |
Enterprise Value | $192.80B | $668.06B |
Dividend Yield | 6.9% | 2.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $24.83, up 0.32% today, with a neutral technical signal and bearish moving averages. The company reported revenue of $62.58B in 2025, with a net income margin of 11.83%, and has beaten EPS estimates for the last three quarters. Recent news highlights pipeline developments in oncology and obesity, with a consensus analyst price target of $28.25.
PFE offers a stable dividend and trades below analyst targets, but faces headwinds from patent expirations and volatile cash flows. The stock presents value with a P/E of 19.04, though growth depends on successful drug launches and navigating post-COVID revenue normalization.
ExxonMobil (XOM) trades at $154.45, up 4.1% on the day, reflecting strong momentum amid bullish technical signals and positive earnings beats. The stock is near its consensus price target of $170.63, with a P/E of 25.54 and solid profitability metrics, including a 7.76% net income margin. Recent news highlights Exxon's Permian Basin advantages and potential oil price spikes, though revenue has trended down from $398.7B in 2022 to $323.9B in 2025.
XOM presents a balanced outlook with upside to analyst targets and a stable dividend, but faces headwinds from declining revenue and net income. Investment appeal hinges on oil price stability and operational execution, while risks include volatile energy markets and geopolitical tensions. The bullish analyst consensus and strong balance sheet support a positive medium-term view.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Exxon Mobil Corporation
Exxon Mobil Corporation operates petroleum and petro chemicals businesses. The Company provides operations include exploration and production of oil and gas, electric power generation, and coal and minerals operations. Exxon Mobil also manufactures and markets fuels, lubricants, and chemicals. Exxon Mobil serves customers worldwide.
Read more on XOM →
